Hsbc Holdings PLC Purchases 51,653 Shares of Bruker Corporation $BRKR

Key Points

• Hsbc Holdings PLC increased its stake in Bruker Corporation by 202.0%, purchasing an additional 51,653 shares to own a total of 77,227 shares worth approximately $3.21 million.
• Bruker Corporation recently missed its quarterly earnings estimate, reporting $0.32 EPS instead of the expected $0.33, alongside a revenue of $797.40 million for the quarter.
• The company announced a quarterly dividend of $0.05 per share, representing an annualized dividend yield of 0.6%, with the payment scheduled for October 3rd.

Hsbc Holdings PLC raised its position in Bruker Corporation (NASDAQ:BRKR - Free Report) by 202.0% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 77,227 shares of the medical research company's stock after buying an additional 51,653 shares during the period. Hsbc Holdings PLC owned about 0.05% of Bruker worth $3,210,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new position in shares of Bruker in the 4th quarter worth $661,000. Tower Research Capital LLC TRC boosted its position in shares of Bruker by 58.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,257 shares of the medical research company's stock worth $425,000 after purchasing an additional 2,687 shares during the last quarter. OneDigital Investment Advisors LLC boosted its position in shares of Bruker by 9.9% in the 4th quarter. OneDigital Investment Advisors LLC now owns 4,002 shares of the medical research company's stock worth $235,000 after purchasing an additional 362 shares during the last quarter. Stifel Financial Corp boosted its position in shares of Bruker by 2.0% in the 4th quarter. Stifel Financial Corp now owns 24,926 shares of the medical research company's stock worth $1,461,000 after purchasing an additional 480 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Bruker by 3.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 549,490 shares of the medical research company's stock worth $32,212,000 after purchasing an additional 19,844 shares during the last quarter. 79.52% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Frank H. Laukien purchased 2,608 shares of the company's stock in a transaction on Friday, June 6th. The shares were purchased at an average price of $38.36 per share, with a total value of $100,042.88. Following the purchase, the chief executive officer directly owned 38,462,171 shares of the company's stock, valued at $1,475,408,879.56. This trade represents a 0.01% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 27.30% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. UBS Group reduced their price target on Bruker from $57.00 to $45.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. The Goldman Sachs Group reduced their price target on Bruker from $50.00 to $45.00 and set a "neutral" rating on the stock in a research report on Thursday, May 8th. Stifel Nicolaus set a $40.00 price target on Bruker and gave the stock a "hold" rating in a research report on Tuesday, August 5th. Bank of America reduced their price target on Bruker from $61.00 to $50.00 and set a "buy" rating on the stock in a research report on Thursday, June 26th. Finally, Barclays dropped their price objective on Bruker from $46.00 to $43.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Five research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $51.30.

Bruker Stock Performance

Shares of Bruker stock opened at $34.06 on Wednesday. The company has a market capitalization of $5.17 billion, a PE ratio of 65.50, a PEG ratio of 2.86 and a beta of 1.16. Bruker Corporation has a 12 month low of $30.00 and a 12 month high of $72.94. The company has a current ratio of 1.61, a quick ratio of 0.70 and a debt-to-equity ratio of 1.31. The stock's fifty day simple moving average is $38.32 and its 200 day simple moving average is $40.63.

Bruker (NASDAQ:BRKR - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The medical research company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.33 by ($0.01). Bruker had a return on equity of 17.89% and a net margin of 2.31%.The business had revenue of $797.40 million for the quarter, compared to analyst estimates of $811.17 million. During the same period in the previous year, the business posted $0.52 EPS. The business's quarterly revenue was down .4% compared to the same quarter last year. Bruker has set its FY 2025 guidance at 1.950-2.050 EPS. On average, research analysts predict that Bruker Corporation will post 2.69 EPS for the current year.

Bruker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 3rd. Shareholders of record on Tuesday, September 23rd will be paid a $0.05 dividend. The ex-dividend date of this dividend is Tuesday, September 23rd. This represents a $0.20 annualized dividend and a dividend yield of 0.6%. Bruker's dividend payout ratio (DPR) is currently 38.46%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.

Want to see what other hedge funds are holding BRKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bruker Corporation (NASDAQ:BRKR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.